Article

South China Morning Post on 2022-12-13 14:26

Moderna’s personalised mRNA cancer vaccine shows promise for next phase of trials

Data from Moderna and Merck skin cancer Phase 2 trials shows an ‘extremely strong result’ for a personalised mRNA cancer vaccine.

Related news

Moderna’s mRNA COVID-19 vaccine delivers promising Phase 1 trial data newatlas.com
Infectious Diseases , Phase 2 , Phase 1
Early trial data for Moderna’s mRNA flu vaccine disappoints newatlas.com
Phase 2 , Phase 1
British patients test world’s first personalised mRNA jab for melanoma expressandstar.com
Stevenage , Edinburgh , Manchester , Phase 2 , Bray
BModerna’s Covid-19 Vaccine Enters Next Phase of Testing barrons.com
Phase 2 , Phase 1
Gennova’s mRNA-based COVID-19 vaccine gets approval for Phase 2/3 clinical trials The Hindu
Phase 1 , India , Phase 2
MModerna’s stock extends rally as experts look to the coming Phase 3 study of the coronavirus vaccine candidate marketwatch.com
Phase 2 , Phase 1 , Wall Street
BModerna’s fresh trials find vaccine still protects against emerging variants businessday.ng
South Africa
‘Paradigm shift’ in cancer treatment as Moderna’s vaccine shows promise Politico.eu
The Vast Promise of mRNA Technology wsj.com
Hungary
Pfizer’s Science Chief Explains Why Its Vaccine Contains Lower mRNA Dose Than Moderna’s observer.com
Belgium
Antria begins Phase 2 trials indianagazette.com
Europe , Asia , North America , Florida , Americas
BNew Data on Moderna’s Covid-19 Vaccine Shows Promise in Older Adults barrons.com
Hong Kong , Phase 2 , Phase 1
Moderna enters clinical trials for its mRNA-based flu vaccine engadget
Yamagata Prefecture , Phase 1
Moderna begins early-stage trials of mRNA-based HIV vaccine engadget
Phase 1
Two more COVID-19 vaccines move towards Phase 2 human trials newatlas.com
Phase 1 , China , Phase 2
Phoenix among U.S. sites for Moderna’s COVID-19 vaccine trials on children tucsonweekly.com
Canada , Phoenix
Vaccine to fight cancer shows promise using mRNA technology Hartford Courant
Chicago , Phase 2
‘Large disruptor’: Moderna’s promise of vaccine ‘cocktail’ could be headache for CSL Sydney Morning Herald
The Market , Australia , Melbourne , Australia